21/17157 - Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season

The Norwegian Institute of Public Health (NIPH) is carrying out procurement of an enhanced quadrivalent vaccine against seasonal influenza for vaccination of people aged 65 or older in nursing homes. Enhanced influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups included in the national immunisation scheme. The procurement is governed by the provisions in parts I and III of the Norwegian Regulations relating to public procurement (Forskrift om offentlige anskaffelser, FOA). The procurement is held as an open tender contest and will be carried out using the electronic competition administration tool (KGV), CTM (EU-Supply).

Varer

31.01.2022 13:00:00

33651660-2  Influensavaksine
33651600-4  Vaksiner